Table 4.
International regulatory status, amendments or monitoring of dispensing for pregabalin and gabapentin.
| Year | Month | Country | Measure |
|---|---|---|---|
| 2005 | July | United States of America (USA) | Pregabalin: Drug Schedule V Controlled Substances (Federal law). |
| 2015 | May | Saoudi Arabia | Pregabalin: Limited prescription, dispensing only in state health-care structures and use of a prescribing register. |
| October | Russia | Pregabalin: Listed as controlled medicine | |
| December | United Arab Emirates | Pregabalin and Gabapentin: List of Controlled Medicines and Medications, Narcotic and Controlled Prescriptions. Limited prescription to 3 days for general practioners, 2 weeks for specialists, 4 weeks in hospital. Prescription validity: once (no possible renewal). Register for prescribers and pharmacies and specific prescription support provided by the Ministry of Health. | |
| 2016 | August | Minnesota (USA) | Gabapentin: Mandated reporting to a PDMP |
| December | Argentina | Pregabalin: Listed as Other Substance for Special Control | |
| Ohio (USA) | Gabapentin: Mandated reporting to a PDMP | ||
| 2017 | February | Virginia (USA) | Gabapentin: Mandated reporting to a PDMP |
| May | Wyoming (USA) | Gabapentin: Mandated reporting to a PDMP | |
| July | Armenia | Pregabalin: Listed as controlled substance | |
| Kentucky (USA) | Gabapentin: Drug Schedule V Controlled Substances with mandated reporting to a PDMP (State law) | ||
| West Virginia (USA) | Gabapentin: Mandated reporting to a PDMP | ||
| August | Massachusetts (USA) | Gabapentin: Mandated reporting to a PDMP | |
| North Dakota (USA) | Gabapentin: Mandated reporting to a PDMP | ||
| November | Turkey | Pregabalin: Prescription validity for 1 year. Specialized opinion (neurologist or psychiatrist) for chronic prescription. Electronic prescription since January 2018. | |
| November | Jordan | Pregabalin: Listed as controlled substance, second table (Drugs, Psychotropic substances and Precursor chemicals appended to the Narcotic Drugs and Psychotropic Substances Law no. 23 of 2016). Limited packaging to 64 tablets. Precribing and dispensing register. | |
| 2018 | January | Nebraska | Gabapentin: Mandated reporting to a PDMP |
| April | Norway | Pregabalin: Schedule B (alongside benzodiazepine) | |
| May | New Jersey (USA) | Gabapentin: Mandated reporting to a PDMP | |
| June | West Virginia (USA) | Gabapentin: Drug Schedule V Controlled Substances (State law) | |
| July | Sweden | Pregabalin: List of substances to be considered narcotics under the Penal Law on Narcotics. | |
| Tennessee (USA) | Gabapentin: Drug Schedule V Controlled Substances | ||
| Kansas (USA) | Gabapentin: “Drug of concern,” mandated reporting to a PDMP | ||
| 2019 | January | Michigan (USA) | Gabapentin: Drug Schedule V Controlled Substances (State law) |
| April | United-Kingdom | Pregabalin and Gabapentin: Category C (prescribing and dispensing restrictions comparable to benzodiazepine) | |
| June | Washington (USA) | Gabapentin: Mandated reporting to a PDMP | |
| July | Virginia (USA) | Gabapentin: Drug Schedule V Controlled Substances (State law) |
PDMP, Prescription Drug Monitoring Program.